The macrophage switch in obesity development (2016)
- Authors:
- Autor USP: CÂMARA, NIELS OLSEN SARAIVA - ICB
- Unidade: ICB
- DOI: 10.3389/fimmu.2015.00637
- Assunto: IMUNOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Immunology
- ISSN: 1664-3224
- Volume/Número/Paginação/Ano: v. 6, art. 637, p. 1-11, 2016
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CASTOLDI, Angela et al. The macrophage switch in obesity development. Frontiers in Immunology, v. 6, p. 1-11, 2016Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2015.00637. Acesso em: 18 abr. 2024. -
APA
Castoldi, A., Souza, C. N. de, Câmara, N. O. S., & Moraes-Vieira, P. M. (2016). The macrophage switch in obesity development. Frontiers in Immunology, 6, 1-11. doi:10.3389/fimmu.2015.00637 -
NLM
Castoldi A, Souza CN de, Câmara NOS, Moraes-Vieira PM. The macrophage switch in obesity development [Internet]. Frontiers in Immunology. 2016 ; 6 1-11.[citado 2024 abr. 18 ] Available from: https://doi.org/10.3389/fimmu.2015.00637 -
Vancouver
Castoldi A, Souza CN de, Câmara NOS, Moraes-Vieira PM. The macrophage switch in obesity development [Internet]. Frontiers in Immunology. 2016 ; 6 1-11.[citado 2024 abr. 18 ] Available from: https://doi.org/10.3389/fimmu.2015.00637 - Pioglitazone limits cyclosporine nephrotoxicity in rats
- The role of toll-like receptor 4 in cisplatin-induced renal injury
- A role for HO-1 in the renal function impairment inrapamucin-treated animals submitted to ischemic and reperfusion injury (IRI)
- Renal transplantation outcomes: a comparative analysis between elderly and younger recipients
- High expression of Tim-3 mRNA in urinary cells from kidney transplant recipients with acute rejection
- Detection of Vbeta11 positive cells inside renal allograft during acute rejection
- PPARg agonists on renal ischemia/reperfusion injury
- Role of PPARy-activation in established chronic cyclosporine nephrotoxicity
- Mesenchymal stem cell therapy in remnant kidney fibrotic model does not improve long term renal outcome
- Imunobiologia do transplante
Informações sobre o DOI: 10.3389/fimmu.2015.00637 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas